Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Awareness: Nucleic Acid–Driven Inflammation and the Type I Interferonopathies
Carolina Uggenti, Alice Lepelley, Yanick J. Crow
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 247-267
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout, Jason D. Katz, Shankar Venkatraman, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 9, pp. 548-569
Open Access | Times Cited: 1369
Interplay between SARS-CoV-2 and the type I interferon response
Margarida Sá Ribeiro, Nolwenn Jouvenet, Marlène Dreux, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 7, pp. e1008737-e1008737
Open Access | Times Cited: 455
Interferon target-gene expression and epigenomic signatures in health and disease
Franck J. Barrat, Mary K. Crow, Lionel B. Ivashkiv
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1574-1583
Open Access | Times Cited: 421
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
Takaki Asano, Bertrand Boisson, Fanny Onodi, et al.
Science Immunology (2021) Vol. 6, Iss. 62
Open Access | Times Cited: 354
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Michael S. Abers, Ottavia M. Delmonte, Emily Ricotta, et al.
JCI Insight (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 335
The type I interferonopathies: 10 years on
Yanick J. Crow, Daniel B. Stetson
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 471-483
Open Access | Times Cited: 309
Regulation of cGAS- and RLR-mediated immunity to nucleic acids
Andrea Ablasser, Sun Hur
Nature Immunology (2019) Vol. 21, Iss. 1, pp. 17-29
Closed Access | Times Cited: 278
Constitutive immune mechanisms: mediators of host defence and immune regulation
Søren R. Paludan, Thomas Pradeu, Seth L. Masters, et al.
Nature reviews. Immunology (2020) Vol. 21, Iss. 3, pp. 137-150
Open Access | Times Cited: 259
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
David S. Pisetsky, Peter E. Lipsky
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 10, pp. 565-579
Open Access | Times Cited: 222
Type I interferon in the pathogenesis of systemic lupus erythematosus
Mariana Postal, Jéssica Fernandes Vivaldo, Ruth Fernandez‐Ruiz, et al.
Current Opinion in Immunology (2020) Vol. 67, pp. 87-94
Open Access | Times Cited: 184
Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling
Alice Lepelley, Maria José Martin-Niclós, Melvin Le Bihan, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 175
A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome
Zimu Deng, Zhenlu Chong, Christopher S. Law, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 151
cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing
Carolina Uggenti, Alice Lepelley, Marine Depp, et al.
Nature Genetics (2020) Vol. 52, Iss. 12, pp. 1364-1372
Open Access | Times Cited: 146
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
Timothy J. Break, Vasileios Oikonomou, Nicolás Dutzan, et al.
Science (2021) Vol. 371, Iss. 6526
Open Access | Times Cited: 127
Human autoantibodies underlying infectious diseases
Anne Puel, Paul Bastard, Jacinta Bustamante, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 95
Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA
Max Paget, Cristhian Cadena, Sadeem Ahmad, et al.
Molecular Cell (2023) Vol. 83, Iss. 7, pp. 1180-1196.e8
Open Access | Times Cited: 74
New frontiers in the cGAS-STING intracellular DNA-sensing pathway
Steve Dvorkin, Stephanie Cambier, Hannah E. Volkman, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 718-730
Open Access | Times Cited: 62
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Meng‐Ju Wu, Hiroshi Kondo, Ashwin V. Kammula, et al.
Science (2024) Vol. 385, Iss. 6705
Closed Access | Times Cited: 18
Human immunity
Jean‐Laurent Casanova
(2025) Vol. 1, Iss. 1
Open Access | Times Cited: 2
Cellular RNA surveillance in health and disease
Sandra L. Wolin, Lynne E. Maquat
Science (2019) Vol. 366, Iss. 6467, pp. 822-827
Open Access | Times Cited: 133
Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach
Peter A. Nigrović, Pui Y. Lee, Hal M. Hoffman
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 5, pp. 925-937
Open Access | Times Cited: 122
STING-associated lung disease in mice relies on T cells but not type I interferon
Hella Luksch, William A. Stinson, Derek J. Platt, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 1, pp. 254-266.e8
Open Access | Times Cited: 111
Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses
Qiannan Tang, Rachel E. Rigby, George R. Young, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 1961-1975.e5
Open Access | Times Cited: 100
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2
C.J. Duncan, Benjamin Thompson, Rui Chen, et al.
Science Immunology (2019) Vol. 4, Iss. 42
Open Access | Times Cited: 91
STING-Mediated Lung Inflammation and Beyond
Marie‐Louise Frémond, Yanick J. Crow
Journal of Clinical Immunology (2021) Vol. 41, Iss. 3, pp. 501-514
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top